Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × pyrotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 30 Brain Neoplasms 4 HER2 Positive Metastatic Breast Cancer 3 Breast Diseases 3 HER2-positive Breast Cancer 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Breast Cancer 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Neoplasm Metastasis 1 HER2+ Early or Locally Advanced Breast Cancer 1 HER2+ Breast Cancer 1 HER2 Positive Gastric Cancer 1 HER2 Positive Breast Cancer 1 HER-2 Positive Colorectal Cancer 1 Estrogen Receptor-positive Breast Cancer 1 Digestive System Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Fluorouracil 18 Oxaliplatin 15 Capecitabine 15 Leucovorin 13 Irinotecan 11 Gemcitabine 10 Drug Therapy 10 Radiosurgery 9 Cisplatin 9 Cetuximab 9 Bevacizumab 9 Docetaxel 8 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 spartalizumab 5 pembrolizumab 5 Sunitinib 5 S 1 (combination) 5 Cyclophosphamide 5 Chemotherapy, Adjuvant 5 Carboplatin 5 manganese chloride 4 Trastuzumab 4 Surgical Procedures, Operative 4 Sorafenib 4 Nivolumab 4 Immunotherapy 4 Fulvestrant 4 Everolimus 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04355858 2022-07-26

MULAN

Fudan University

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡